Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02386514 · ClinicalTrials.gov registry record
Emergency Department, Rapid Assessment for Sexually Transmitted Infection
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 1,200
- Enrollment target
NCT02386514: Completed study, sponsored by Henry Ford Health System.
NCT02386514 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 1,200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02386514 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 1,200 participants
- Enrollment target
Study Summary
To evaluate if a rapid urine Nucleic Acid Amplification Testing (NAAT) is non-inferior to the traditional swab NAAT for gonorrhea and chlamydia when performed in the Emergency Department.
Primary Outcome
comparative test characteristics to traditional swab in the Emergency Department.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2016-06 |
| Est. Completion | 2016-06 |
What the finished NCT02386514 record still lists
NCT02386514 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02386514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02386514 about?
NCT02386514 is a clinical study titled "Emergency Department, Rapid Assessment for Sexually Transmitted Infection". To evaluate if a rapid urine Nucleic Acid Amplification Testing (NAAT) is non-inferior to the traditional swab NAAT for gonorrhea and chlamydia when performed in the Emergency Department.
What is the current status of trial NCT02386514?
This trial is currently completed. The enrollment target is 1,200 participants. The study started on 2016-06. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT02386514?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia